CAS: 1346705-53-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | DHODH-IN-23 REF: IN-DA0294HNCAS: 1346705-53-0 | 98% | A consultar | Vie 09 May 25 |
 | DHODH-IN-23 REF: 54-BUP06547CAS: 1346705-53-0 | ≥98% | 263,00 €~1.199,00 € | Lun 12 May 25 |
 | DHODH-IN-23 REF: TM-T67875CAS: 1346705-53-0 | 98.1% | A consultar | Lun 12 May 25 |
Ref: IN-DA0294HN
| 25mg | 552,00 € | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 9 de Mayo de 2025
Ref: 54-BUP06547
| 25mg | 263,00 € | ||
| 50mg | 394,00 € | ||
| 100mg | 560,00 € | ||
| 500mg | 1.199,00 € |
Entrega estimada en Estados Unidos, el Lunes 12 de Mayo de 2025
DHODH-IN-23
CAS:1346705-53-0
DHODH-IN-23 is a DHODH inhibitor with oral activity. DHODH-IN-23 is often used in cancer research.
Fórmula:
C24H21ClFNO4
Pureza:
98.1%
Forma y color:
Solid
Peso molecular:
441.88
Ref: TM-T67875
| 5mg | 52,00 € | ||
| 10mg | 84,00 € | ||
| 25mg | 170,00 € | ||
| 50mg | 259,00 € | ||
| 100mg | 375,00 € | ||
| 500mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 12 de Mayo de 2025
